Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats

Journal of Nutrition

Volumn 143, Issue 6, 2013, Pages 835-842

  Allam, Farida ^a   Dao, An T ^a   Chugh, Gaurav ^a   Bohat, Ritu ^a   Jafri, Faizan ^a   Patki, Gaurav ^a   Mowrey, Christopher ^a   Asghar, Mohammad ^a   Alkadhi, Karim A ^a   Salim, Samina ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUTHIONINE SULFOXIMINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTATHIONE REDUCTASE; GLUTATHIONE REDUCTASE 1; GLYOXALASE; GLYOXALASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TAP WATER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; ENZYME ACTIVATION; GRAPE; HYPERTENSION; LEARNING; LONG TERM MEMORY; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POWDER; RAT; SHORT TERM MEMORY; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUTHIONINE SULFOXIMINE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOOD, PRESERVED; FREEZE DRYING; FRUIT; GLUTATHIONE REDUCTASE; HYPERTENSION; LACTOYLGLUTATHIONE LYASE; MALE; MEMORY DISORDERS; OXIDATIVE STRESS; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; VITIS;

EID: 84878254146     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.174649     Document Type: Article

References (55)

1. Ciobica A, Padurariu M, Bild W, Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. Psychiatr Danub. 2011;23:340-6.
2. Curtin MLI. Chronic illness-impact and interventions. 2nd ed. Boston: Jones and Bartlett Publishers; 1990.
3. Carroll D, Phillips AC, Gale CR, Batty GD. Generalized anxiety and major depressive disorders, their comorbidity and hypertension in middle-aged men. Psychosom Med. 2010;72:16-9.
4. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertension. 2010;56:547-50.
5. Jacobs U, De Castro MS, Fuchs FD, Ferreira MB. The influence of cognition, anxiety and psychiatric disorders over treatment adherence in uncontrolled hypertensive patients. PLoS ONE. 2011;6:e22925.
6. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997;6:43-9.
7. Salim S, Sarraj N, Taneja M, Saha K, Tejada-Simon MV, Chugh G. Moderate treadmill exercise prevents oxidative stress-induced anxietylike behavior in rats. Behav Brain Res. 2010;208:545-52.
8. Salim S, Asghar M, Chugh G, Taneja M, Xia Z, Saha K. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res. 2010;1359:178-85.
9. Banday AA, Lau YS, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension. 2008;51:367-75.
10. Banday AA, Lokhandwala MF. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptornitric oxide signaling. Hypertension. 2008;52:1099-105.
11. Bouayed J, Rammal H, Younos C, Soulimani R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol. 2007;564:146-9.
12. de Oliveira MR, Silvestrin RB, Mello EST, Moreira JC. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of subacute vitamin A supplementation at therapeutic doses. Neurotoxicology. 2007;28: 1191-9.
13. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, Ellison JA, Schadt EE, Verma IM, Lockhart DJ. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature. 2005;438: 662-6.
14. Masood A, Nadeem A, Mustafa SJ, O'Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther. 2008;326:369-79.
15. Souza CG, Moreira JD, Siqueira IR, Pereira AG, Rieger DK, Souza DO, Souza TM, Portela LV, Perry ML. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci. 2007;81:198-203.
16. Vollert C, Zagaar M, Hovatta I, Taneja M, Vu A, Dao A, Levine A, Alkadhi K, Salim S. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav Brain Res. 2011;224:233-40.
17. Alhaider IA, Aleisa AM, Tran TT, Alzoubi KH, Alkadhi KA. Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep. 2010;33:437-44.
18. Pezzuto JM, Venkatasubramanian V, Hamad M, Morris KR. Unraveling the relationship between grapes and health. J Nutr. 2009;139:1783S-7S.
19. Pezzuto JM. Grapes and human health: a perspective. J Agric Food Chem. 2008;56:6777-84.
20. Chen RS, Wu PL, Chiou RY. Peanut roots as a source of resveratrol. J Agric Food Chem. 2002;50:1665-7.
21. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal. 1997;11:287-313.
22. Jang JH, Surh YJ. Protective effect of resveratrol on beta-amyloidinduced oxidative PC12 cell death. Free Radic Biol Med. 2003;34: 1100-10.
23. Virgili M, Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett. 2000;281:123-6.
24. Zhuang H, Kim YS, Koehler RC, Dore S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N YAcad Sci. 2003;993:276-86, discussion 87-8.
25. Fuhrman B, Volkova N, Coleman R, Aviram M. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr. 2005;135:722-8.
26. Sönmez U, Sonmez A, Erbil G, Tekmen I, Baykara B. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett. 2007;420:133-7.
27. Vislocky LM, Fernandez ML. Biomedical effects of grape products. Nutr Rev. 2010;68:656-70.
28. Asghar M, Chugh G, Lokhandwala MF. Inflammation compromises renal dopamine D1 receptor function in rats. Am J Physiol Renal Physiol. 2009;297:F1543-9.
29. Paxinos G and Watson C. The rat brain stereotaxic coordinates. 6th ed. Academic Press; 1986.
30. Franco JG, Lisboa PC, Lima NS, Amaral TA, Peixoto-Silva N, Resende AC, Oliveira E, Passos MC, Moura EG. Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning. J Nutr Biochem. 2012.
31. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609-23.
32. Salim S, Asghar M, Taneja M, Hovatta I, Chugh G, Vollert C, Vu A. Potential contribution of oxidative stress and inflammation to anxiety and hypertension. Brain Res. 2011;1404:63-71.
33. Esposito F, Ammendola R, Faraonio R, Russo T, Cimino F. Redox control of signal transduction, gene expression and cellular senescence. Neurochem Res. 2004;29:617-28.
34. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol. 2003;15:247-54.
35. Flohé L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med. 1997;22: 1115-26.
36. Klann E, Thiels E. Modulation of protein kinases and protein phosphatases by reactive oxygen species: implications for hippocampal synaptic plasticity. Prog Neuropsychopharmacol Biol Psychiatry. 1999; 23:359-76.
37. Serrano F, Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev. 2004;3:431-43.
38. Ailing F, Fan L, Li S, Manji S. Role of extracellular signal-regulated kinase signal transduction pathway in anxiety. J Psychiatr Res. 2008;43: 55-63.
39. Mazzucchelli C, Brambilla R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol Life Sci. 2000;57: 604-11.
40. Qi X, Lin W, Li J, Pan Y, Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res. 2006;175:233-40.
41. Reul JM, Chandramohan Y. Epigenetic mechanisms in stress-related memory formation. Psychoneuroendocrinology. 2007;32 Suppl 1: S21-5.
42. Shin JA, Lee KE, Kim HS, Park EM. Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochem Res. 2012.
43. Charney DS, Drevets WC. The neurobiological basis of anxiety disorders. The American college of Neuropsychopharmacology; 2002.
44. Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67-79.
45. Elam M, Svensson TH, Thoren P. Differentiated cardiovascular afferent regulation of locus coeruleus neurons and sympathetic nerves. Brain Res. 1985;358:77-84.
46. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, Pratt JH. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481-7.
47. Femenìa T, Gomez-Galan M, Lindskog M, Magara S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012;1476:58-70.
48. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev. 2001;38:192-246.
49. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci. 1988;8:2517-29.
50. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23:7311-6.
51. Pandey SC. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci. 2003;24:456-60.
52. Abel T, Kandel E. Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res Brain Res Rev. 1998;26: 360-78.
53. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54:597-606.
54. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997;23:134-47.
55. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009;1250:242-53.